Medicines A–Z
F
| Status | Drug name | NICE TAs | Comments |
|---|---|---|---|
 |
Fluphenazine decanoate injection | Hospital only. APC verdict - present status red. Future status amber with a framework in primary care before transfer (commissioning discussion). |
|
 |
Flutamide tablets | ||
|
Fluticasone | ||
 |
Fluticasone and formoterol (Flutiform®) | ||
|
Fluticasone furoate & vilanterol (Relvar Ellipta®) | 92mcg/22mcg - In line with COPD Guidance |
|
|
Fluticasone nebulised (Flixotide) | ||
|
Fluticasone propionate nasal drops (Flixonase Nasule) | Specialist recommendation for nasal polyps. |
|
|
Fluticasone with Umeclidium and Vilanterol (Trelegy Ellipta) | ||
|
Fluvastatin capsules | ||
|
Folic acid SF solution (Lexpex) |
Drug status key
Formulary drugs are allocated a traffic light status. This provides guidance on where clinical and prescribing responsibilities lie in regard to the initiation and maintenance of prescribing.
Grey
Positive NICE TA and/or awaiting local clarification on place in therapy. Please contact your medicines optimisation team for more information.
Red
Initiation and maintenance of prescribing by specialists only.
Amber
Initiation and maintenance of prescribing by specialists and transfer to primary care prescribing when appropriate, or in primary care following a specialists recommendation. Prior to initiation some medicines may require committee agreement or a framework to support safe transfer and maintenance.
Green
Initiation and maintenance of prescribing by specialists, GPs and other qualified clinicians.
Blue
Under review at University Hospitals Birmingham NHS Foundation Trust.
